Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Benefits of µCor in Ambulatory Decompensated Heart Failure

ClinicalTrials.gov ID: NCT03476187

Public ClinicalTrials.gov record NCT03476187. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 26, 2026, 11:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Subjects meeting the inclusion/exclusion criteria will wear the µCor for at least 90 days. During the study, clinic follow up will occur every 30 days. For all subjects, each scheduled clinic visit will include assessment of cardiac symptoms and any relevant clinically actionable events. The subject will be given a daily diary to track symptoms, unplanned hospital visits, medication changes, and all other heart failure related clinical events. Weekly phone calls to the subject will be given throughout the duration of the study to remind the patient to use the subject diary and to collect and record heart failure related clinical events. Subjects will be contacted six months and one year from initial enrollment to assess the vital status of the subject, any heart failure related clinical events since the end of µCor wear, and any health care utilization since the end of µCor wear.

Study identification

NCT ID
NCT03476187
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Zoll Medical Corporation
Industry
Enrollment
257 participants

Conditions and interventions

Conditions

Interventions

Device

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 16, 2018
Primary completion
Jan 7, 2024
Completion
Apr 8, 2024
Last update posted
Jan 7, 2025

2018 – 2024

United States locations

U.S. sites
57
U.S. states
22
U.S. cities
52
Facility City State ZIP Site status
Mobile Heart Specialists, PC Mobile Alabama 36608 —
University Hospital Mobile Alabama 36617 —
NEA Baptist Clinic Jonesboro Arkansas 72405 —
Cardiovascular Innovation and Research Center, Inc. Long Beach California 90813 —
Los Alamitos Cardiovascular Los Alamitos California 90720 —
Nova Clinical Research LLC Bradenton Florida 34209 —
South Palm Cardiovascular Research Institute Delray Beach Florida 33446 —
Holy Cross Medical Group Fort Lauderdale Florida 33308 —
The Cardiac and Vascular Institute Research Foundation Gainesville Florida 32605 —
Baptist Heart Specialists Jacksonville Florida 32250 —
The Heart Institute at Largo Largo Florida 33770 —
Mount Sinai Medical Center Miami Beach Florida 33140 —
Cardiovascular Institute of Central Florida Ocala Florida 34471 —
Northside Hospital St. Petersburg Florida 33709 —
University of South Florida Dept of Cardiovascular Sciences Tampa Florida 33609 —
Cardiology Practice Tampa Tampa Florida 33613 —
Cardiovascular Consultants of South Georgia Thomasville Georgia 31792 —
Fox Valley Clinical Research Center Aurora Illinois 60506 —
The Loretto Hospital Chicago Illinois 60644 —
Chicago Medical Research LLC Hazel Crest Illinois 60429 —
Loyola University Medical Center Maywood Illinois 60153 —
Unity Point Health Cardiovascular Services Peoria Illinois 61606 —
DuPage Medical Group Winfield Illinois 60190 —
Grace Research LLC Bossier City Louisiana 71111 —
Clinical Trials of America, LLC Monroe Louisiana 71201 —
Clinical Trials of America, LLC West Monroe Louisiana 71291 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Cardiology Institute of Michigan Flint Michigan 48507 —
Hennepen Healthcare Research Institute Minneapolis Minnesota 55415 —
Nebraska Heart Institute Grand Island Nebraska 68803 —
Nebraska Heart Institute Lincoln Nebraska 68526 —
University Medical Center of Southern Nevada Las Vegas Nevada 89102 —
New Jersey Heart Linden New Jersey 07036 —
AtlantiCare Regional Medical Center Pomona New Jersey 08240 —
Trinity Medical WNY Buffalo New York 14215 —
SJH Cardiology Associates Liverpool New York 13088 —
University of Rochester Medical Center Rochester New York 14642 —
East Carolina Heart Institute Greenville North Carolina 27834 —
NC Heart & Vascular Research Raleigh North Carolina 27607 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 —
OUHSC Oklahoma City Oklahoma 73104 —
UMPC Hamot Erie Pennsylvania 16550 —
Lancaster General Hospital Lancaster Pennsylvania 17602 —
The Guthrie Clinic Sayre Pennsylvania 18840 —
Cardiology Consultants of Philadelphia Yardley Pennsylvania 19067 —
Palmetto Health Advanced Heart Health Center Columbia South Carolina 29203 —
The Jackson Clinic, PA Jackson Tennessee 38301 —
PharmaTex Research Amarillo Texas 79106 —
JPS Health Network Fort Worth Texas 76104 —
Texas Cardiovascular Institute Fort Worth Texas 76104 —
Northwest Houston Cardiology Houston Texas 77070 —
CardioVogage McKinney Texas 75071 —
Texas Institute of Cardiology McKinney Texas 75071 —
Riverside Hospital Inc. Newport News Virginia 23601 —
Chippenham Hospital Richmond Virginia 23225 —
Henrico Doctors Hospital Richmond Virginia 23229 —
Marshall Cardiology Huntington West Virginia 25701 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03476187, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 7, 2025 · Synced Sep 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03476187 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →